  
<prompt> National-Level Trends in IPTp 3+
 Percent of women age 15-49 with a live birth in the past two years who, during their last pregnancy, received atleast 3 or more doses of SP/Fansidar who received atleast one dose during an antenatal care visit. 
 [["EDSB-III 2006", 1], ["EDSB-IV 2011-2012", 9], ["EDSB-V 2017-2018", 13]] 
 <response> Only 13% of women age 15-49 with a live birth in the two years before the survey received three or more doses of SP/Fansidar, at least one during an antenatal visit. Coverage of IPTp 3+ increased significantly from 1% in 2006 to 9% in 2011-2012 to 13% in 2017-2018.  